ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,460.48
      -0.41%
      US Tech 100
      19,181.60
      -0.43%
      Dow Jones
      39,118.86
      -0.12%
      Brent Oil
      84.85
      0.00%
      Bitcoin
      61,607.69
      1.18%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Five Prime Therapeutics Inc (FPRX)

      7. Five Prime Therapeutics Inc (FPRX) News

      FPRX

      Five Prime Therapeutics (FPRX)

      Five Prime Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:FPRX
      DateTimeSourceHeadlineSymbolCompany
      06/26/20194:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      06/25/20194:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      06/25/20194:08PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FPRXFive Prime Therapeutics Inc
      06/24/20194:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FPRXFive Prime Therapeutics Inc
      06/24/20194:05PMBusiness WireFive Prime Therapeutics Appoints Lori Lyons-Williams to its Board of DirectorsNASDAQ:FPRXFive Prime Therapeutics Inc
      06/12/20196:38PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:FPRXFive Prime Therapeutics Inc
      06/12/20196:29PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      06/12/20196:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      06/12/20196:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      06/12/20196:21PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      06/12/20196:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      06/12/20196:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      06/12/20196:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      06/10/20194:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FPRXFive Prime Therapeutics Inc
      06/10/20191:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      06/09/20193:05PMBusiness WireFive Prime Therapeutics Announces the Departure of Dr. Sheila Gujrathi From its Board of DirectorsNASDAQ:FPRXFive Prime Therapeutics Inc
      06/09/20193:00PMBusiness WireFive Prime Therapeutics to Present at Two Upcoming Healthcare ConferencesNASDAQ:FPRXFive Prime Therapeutics Inc
      06/01/20199:01AMBusiness WireFive Prime Therapeutics Presents Monotherapy Data From the Phase 1a/1b Trial of FPA150 in Patients With Advanced Solid Tumors...NASDAQ:FPRXFive Prime Therapeutics Inc
      05/24/20194:01PMBusiness WireFive Prime Therapeutics to Present at Two Upcoming Healthcare ConferencesNASDAQ:FPRXFive Prime Therapeutics Inc
      05/16/20196:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      05/16/20196:35PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:FPRXFive Prime Therapeutics Inc
      05/16/20196:30PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:FPRXFive Prime Therapeutics Inc
      05/16/20194:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FPRXFive Prime Therapeutics Inc
      05/15/20196:39PMBusiness WireFive Prime Therapeutics Appoints Carol Schafer to its Board of DirectorsNASDAQ:FPRXFive Prime Therapeutics Inc
      05/15/20195:45PMBusiness WireFive Prime Therapeutics Announces FPA150 Poster Presentation at the 2019 ASCO Annual MeetingNASDAQ:FPRXFive Prime Therapeutics Inc
      05/09/20195:14PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:FPRXFive Prime Therapeutics Inc
      05/08/20194:14PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:FPRXFive Prime Therapeutics Inc
      05/08/20194:05PMBusiness WireFive Prime Therapeutics Reports First Quarter 2019 ResultsNASDAQ:FPRXFive Prime Therapeutics Inc
      05/02/20191:22PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:FPRXFive Prime Therapeutics Inc
      05/02/20191:17PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (3/a)NASDAQ:FPRXFive Prime Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:FPRX

      Your Recent History

      BIT
      P14SF5
      BNP Paribas Issuance
      Delayed Upgrade Clock